PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator Device in ALS
February 04, 2025 06:00 ET
|
PathMaker Neurosystems Inc.
PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator® Device in ALS which will take place at BIDMC in Boston
Radical Catheter Technologies’ 8F Neurovascular Catheter Receives US FDA 510(k) Clearance, Second for the Best-in-Class Ribbon Technology Platform
January 15, 2025 09:00 ET
|
Radical Catheter Technologies
CAMPBELL, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Radical™ Catheter Technologies, a pioneering medical device company focused on advancing the next generation of endovascular access and delivery,...
E8, Inc. Announces Collaborative Partnership with Jacobs Institute to Make Minimally Invasive Solutions the Gold Standard in Neurosurgery
January 14, 2025 08:00 ET
|
E8, Inc.
LOS GATOS, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- E8, Inc. unveiled its next-generation suite of tools designed to turn the promise of minimally invasive neurosurgical access devices, including...
Borvo Medical Announces U.S. FDA 510(k) Clearance for Innovative Surgical Device, Offering a Minimally Invasive Option for Surgical Brain Treatment
October 08, 2024 08:00 ET
|
Borvo Medical
Borvo EVAC™ System Provides Advanced Approach for the Growing Number of PatientsRequiring Subdural Hematoma (SDH) Drainage Driven by Factors Such as Head Injuries and an Aging Population MOUNTAIN...
Neurotech Innovation Achieves Patent Approval and Featured Cover Story in Prominent Industry Journal
August 09, 2024 09:00 ET
|
Longeviti Neuro Solutions
Longeviti, a neurotechnology company with a focus on innovative solutions for complex brain surgeries, announced its patent for its ClearFit Implant.
Radical™ Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery (SNIS) 21st Annual Meeting
July 22, 2024 17:00 ET
|
Radical Catheter Technologies
CAMPBELL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Radical™ Catheter Technologies, a medical device company pioneering the next generation of endovascular access and delivery products, today...
PathMaker Neurosystems Announces $2.16 Million Award from U.S. Department of Defense for ALS Clinical Trial
June 05, 2024 06:00 ET
|
PathMaker Neurosystems Inc.
PathMaker Neurosystems receives $2.16 million award from United States Department of Defense for an expanded ALS clinical trial of its MyoRegulator device
Brain Computer Interface Market to Reach USD 7,419.0 Mn by 2033; Amid Growing Research on Neural Interfaces and Cognitive Computing
February 13, 2024 06:37 ET
|
Market.Us
New York, Feb. 13, 2024 (GLOBE NEWSWIRE) -- According to Market.us, The Brain Computer Interface Market is projected to be worth USD 2,071.1 Million in 2023. The market is likely to reach USD...
Neurotechnology Research Report 2024: Market Set to Surge, North America Leads Growth Trajectory - Long-term Forecast to 2028 and 2033
January 30, 2024 10:49 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Neurotechnology Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The report reveals that the neurotechnology...
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
September 14, 2023 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...